SCHEMBL29664607

SCHEMBL29664607

O=C(O)c1cc(-c2noc(-c3ccccc3F)n2)ccc1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.70
BLVRB P30043 1/20 0.70
HDAC6 Q9UBN7 1/20 0.70
ACMSD Q8TDX5 4/20 0.67
NPC1 O15118 12/20 0.66
RAB9A P51151 12/20 0.66
KMT2A Q03164 5/20 0.62
SMN1; SMN2 Q16637 5/20 0.62
MEN1 O00255 4/20 0.62
NFKB1 P19838 3/20 0.62
NFKB2 Q00653 3/20 0.62
RELA Q04206 3/20 0.62
L3MBTL1 Q9Y468 2/20 0.62
PKM P14618 2/20 0.62
MAPK1 P28482 1/20 0.62
MAPT P10636 2/20 0.53
TP53 P04637 1/20 0.53
CHUK O15111 1/20 0.51
CASP3 P42574 1/20 0.51
TXNRD1 Q16881 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL384904 1.00 MAOA (0.70) MAOABLVRBHDAC6ACMSDNPC1
SCHEMBL385108 0.88 MAOA (0.66) MAOABLVRBHDAC6ACMSDNPC1
SCHEMBL385293 0.85 NPC1 (0.73) MAOABLVRBHDAC6ACMSDNPC1
SCHEMBL12171151 0.83 NPC1 (0.78) MAOABLVRBHDAC6NPC1RAB9A
Ataluren SCHEMBL29365205 0.82 MAOA (1.00) MAOABLVRBHDAC6NPC1RAB9A
Ataluren SCHEMBL29361641 0.82 MAOA (1.00) MAOABLVRBHDAC6NPC1RAB9A
Ataluren SCHEMBL60614 0.82 MAOA (1.00) MAOABLVRBHDAC6NPC1RAB9A
Ataluren SCHEMBL29360108 0.82 MAOA (1.00) MAOABLVRBHDAC6NPC1RAB9A
SCHEMBL387630 0.81 NPC1 (0.67) MAOABLVRBHDAC6ACMSDNPC1
Ataluren SCHEMBL59167 0.81 MAOA (0.97) MAOABLVRBHDAC6NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240059656-A1 A TAUTOMERIC LIGAND ENABLES BIOMIMETIC C-H HYDROXYLATION WITH MOLECULAR OXYGEN THE SCRIPPS RESEARCH INSTITUTE 2024-02-22 US disclosed
WO-2022125736-A1 A TAUTOMERIC LIGAND ENABLES BIOMIMETIC C-H HYDROXYLATION WITH MOLECULAR OXYGEN THE SCRIPPS RESEARCH INSTITUTE (US) 2022-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240059656-A1 A TAUTOMERIC LIGAND ENABLES BIOMIMETIC C-H HYDROXYLATION WITH MOLECULAR OXYGEN PAH, OGDH, DOHH MAOA 42/4885BLVRB 213/4885HDAC6 2493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.